GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (XBUL:22UA) » Definitions » Inventory-to-Revenue

BioNTech SE (XBUL:22UA) Inventory-to-Revenue : 0.25 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BioNTech SE Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioNTech SE's Average Total Inventories for the quarter that ended in Sep. 2024 was лв651 Mil. BioNTech SE's Revenue for the three months ended in Sep. 2024 was лв2,561 Mil. BioNTech SE's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.25.

BioNTech SE's Inventory-to-Revenue for the quarter that ended in Sep. 2024 declined from Jun. 2024 (2.68) to Jun. 2024 (0.25)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BioNTech SE's Days Inventory for the three months ended in Sep. 2024 was 161.42.

Inventory Turnover measures how fast the company turns over its inventory within a year. BioNTech SE's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.57.


BioNTech SE Inventory-to-Revenue Historical Data

The historical data trend for BioNTech SE's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Inventory-to-Revenue Chart

BioNTech SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventory-to-Revenue
Get a 7-Day Free Trial 0.08 0.08 0.02 0.03 0.10

BioNTech SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.26 1.88 2.68 0.25

Competitive Comparison of BioNTech SE's Inventory-to-Revenue

For the Biotechnology subindustry, BioNTech SE's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNTech SE's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioNTech SE's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioNTech SE's Inventory-to-Revenue falls into.



BioNTech SE Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioNTech SE's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Inventory-to-Revenue (A: Dec. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )
=( (863.283 + 723.131) / 2 ) / 7720.54
=793.207 / 7720.54
=0.10

BioNTech SE's Inventory-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue (Q: Sep. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2024 ) + Total Inventories (Q: Sep. 2024 )) / count ) / Revenue (Q: Sep. 2024 )
=( (678.669 + 623.632) / 2 ) / 2561.192
=651.1505 / 2561.192
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNTech SE  (XBUL:22UA) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioNTech SE's Days Inventory for the three months ended in Sep. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2024 )/Cost of Goods Sold (Q: Sep. 2024 )*Days in Period
=651.1505/368.089*365 / 4
=161.42

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioNTech SE's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2024 ) / Average Total Inventories (Q: Sep. 2024 )
=368.089 / 651.1505
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNTech SE Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNTech SE Business Description

Address
An der Goldgrube 12, Mainz, RP, DEU, D-55131
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

BioNTech SE Headlines

No Headlines